Crossmark

Chromatin remodellers as therapeutic targets

Crossref DOI link: https://doi.org/10.1038/s41573-024-00978-5

Published Online: 2024-07-16

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Malone, Hayden A. http://orcid.org/0000-0002-0537-797X
Roberts, Charles W. M. http://orcid.org/0000-0003-1135-1896
License Information

Text and Data Mining valid from 2024-07-16

Version of Record valid from 2024-07-16
More Information

Article History

Accepted: 28 May 2024

First Online: 16 July 2024

Competing interests

: C.W.M.R. is a scientific advisory board member of Exo Therapeutics, unrelated to this manuscript.